Quantitative Benefit-Risk Assessment of COVID-19 Vaccines Using the Multi-Criteria Decision Analysis.

Son, Kyung-Hwa; Kwon, Sun-Hong; Na, Hye-Jung; Baek, Youngsuk; Kim, Inok; Lee, Eui-Kyung

Son, Kyung-Hwa; Kwon, Sun-Hong; Na, Hye-Jung; Baek, Youngsuk; Kim, Inok; Lee, Eui-Kyung.

Afiliação

Son KH; School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.
Kwon SH; School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.
Na HJ; School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.
Baek Y; School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.
Kim I; School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.
Lee EK; School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.

Vaccines (Basel) ; 10(12)2022 Nov 27.

Article em En | MEDLINE | ID: mdl-36560439

Palavras-chave

COVID-19 vaccine; SARS-CoV-2; multi-criteria decision analysis; quantitative benefit-risk assessment

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 Problema de saúde: 1_financiamento_saude / 1_recursos_humanos_saude Tipo de estudo: Etiology_studies / Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google